Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society* clinical practice guideline
Author(s)
Type
Journal Article
Abstract
Objective
To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010.
Conclusions
The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.
To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010.
Conclusions
The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.
Date Issued
2018-11-01
Date Acceptance
2018-08-27
Citation
Journal of Clinical Endocrinology and Metabolism (JCEM), 2018, 103 (11), pp.4043-4088
ISSN
0021-972X
Publisher
Oxford University Press
Start Page
4043
End Page
4088
Journal / Book Title
Journal of Clinical Endocrinology and Metabolism (JCEM)
Volume
103
Issue
11
Copyright Statement
Copyright © 2018 Endocrine Society
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30272171
PII: 5107759
Subjects
BONE-MINERAL DENSITY
DECREASED EPINEPHRINE RESERVE
DRIED BLOOD SPOTS
Endocrinology & Metabolism
GENDER-ROLE BEHAVIOR
Life Sciences & Biomedicine
LONG-TERM CURE
NEONATAL SCREENING-PROGRAM
PRENATAL DEXAMETHASONE EXPOSURE
QUALITY-OF-LIFE
REST TUMORS
Science & Technology
TANDEM MASS-SPECTROMETRY
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-09-27